Questions a plan sponsor actually asks.
What is Doxylamine and Pyridoxine Hydrochloride, Delayed Release Tablets used for?
Doxylamine and Pyridoxine Hydrochloride, Delayed Release Tablets is a this drug class medication tracked in Medicare Part D.
Is there a generic for Doxylamine and Pyridoxine Hydrochloride, Delayed Release Tablets?
No. Doxylamine and Pyridoxine Hydrochloride, Delayed Release Tablets is brand-only with no generic equivalents currently in market.
How much does my plan pay for Doxylamine and Pyridoxine Hydrochloride, Delayed Release Tablets?
Across 329 Part D plans, Doxylamine and Pyridoxine Hydrochloride, Delayed Release Tablets averages $1.16/unit (NADAC). Lowest available: $1.16/unit. Highest in distribution: $1.16/unit.
Is Doxylamine and Pyridoxine Hydrochloride, Delayed Release Tablets on the FDA shortage list?
No. Doxylamine and Pyridoxine Hydrochloride, Delayed Release Tablets is not currently on the FDA Drug Shortage Database.
3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.